Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature
Abstract
To assess the efficacy and safety of Rituximab (RTX) in adult primary central nervous system vasculitis (PCNSV).We retrospectively assessed the effect of RTX in 6 patients with PCNSV. Five of the 6 were refractory to high dose glucocorticoids (GCs) and/or conventional immunosuppressants (IS). The sixth was newly diagnosed and received RTX in combination with GCs. Clinical evaluation, laboratory tests, and imaging modalities were performed at...
Paper Details
Title
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature
Published Date
Apr 1, 2019
Journal
Volume
18
Issue
4
Pages
399 - 405
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History